Exploring the frontier of pharmaceutical innovation
Daewoong Therapeutics R&D
Discover Daewoong Therapeutics’ Research & Development in Microneedle Technology
We are advancing innovative drug delivery solutions through microneedle platforms, aiming to enhance patient compliance and enable next-generation therapeutics across multiple disease areas.
CLOPAM® (Closed-Packed Aero-Pressured Microneedle) – Technology Overview

Drug Layer / Base Layer
Early-stage Microneedle Patch Sample
3D Schematic of CLOPAM® Patches
Patent for Microneedle Fabrication Method
CLOPAM® (Closed-Packed Aero-Pressured Microneedle) – Key Benefits
Daewoong Therapeutics’ proprietary CLOPAM® platform is optimized for pharmaceutical applications. Hermetic packaging of individual needles maximizes the stability of both microneedles and drug substances and enables scalability for mass production.
Partner with Us
We are actively recruiting partners with investigative and marketed ingredients for strategic development of pharmaceutical microneedle products
Patient-friendly product for better compliance

Room-temperature storage for biopharmaceutical agents

Extension of drug patent life

Increased market share and revenue
